BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$981M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$944M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$873M |
| 5 |
Microsoft
MSFT
|
+$816M |
Top Sells
| 1 |
Home Depot
HD
|
+$243M |
| 2 |
Fiserv
FI
|
+$152M |
| 3 |
American Tower
AMT
|
+$144M |
| 4 |
Tesla
TSLA
|
+$138M |
| 5 |
Uber
UBER
|
+$112M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Financials | 12.31% |
| 3 | Consumer Discretionary | 8.67% |
| 4 | Healthcare | 6.81% |
| 5 | Communication Services | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Hawkins
HWKN
$3.62B
| $222K | ﹤0.01% |
6,634
+2,244
| +51% | +$75.2K |
|
2327
Monarch Casino & Resort
MCRI
$1.9B
| $222K | ﹤0.01% |
3,664
+1,045
| +40% | +$63.3K |
|
2328
BCE
BCE
$22.5B
| $221K | ﹤0.01% |
4,900
| – | – |
|
2329
MBIA
MBI
$393M
| $221K | ﹤0.01% |
22,946
-607
| -3% | -$5.84K |
|
2330
Iovance Biotherapeutics
IOVA
$821M
| $221K | ﹤0.01% |
6,966
+2,025
| +41% | +$64.1K |
|
2331
Tredegar Corp
TG
$279M
| $220K | ﹤0.01% |
14,687
+7,009
| +91% | +$105K |
|
2332
AXT Inc
AXTI
$169M
| $220K | ﹤0.01% |
18,878
+7,768
| +70% | +$90.6K |
|
|
GTHX
2333
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $219K | ﹤0.01% |
9,113
+4,807
| +112% | +$116K |
|
2334
PetMed Express
PETS
$57.8M
| $219K | ﹤0.01% |
6,229
-2,845
| -31% | -$100K |
|
2335
Scotiabank
BNS
$78.7B
| $219K | ﹤0.01% |
3,500
| – | – |
|
2336
Penske Automotive Group
PAG
$11.9B
| $217K | ﹤0.01% |
2,706
-21,345
| -89% | -$1.71M |
|
2337
Viking Therapeutics
VKTX
$2.79B
| $217K | ﹤0.01% |
34,254
+25,088
| +274% | +$159K |
|
2338
Santander
BSBR
$40.1B
| $216K | ﹤0.01% |
32,056
+3,432
| +12% | +$23.2K |
|
|
MSGN
2339
DELISTED
MSG Networks Inc.
MSGN
| $215K | ﹤0.01% |
14,326
+4,456
| +45% | +$67K |
|
2340
Business First Bancshares
BFST
$723M
| $215K | ﹤0.01% |
9,003
+4,557
| +102% | +$109K |
|
|
GNMK
2341
DELISTED
GenMark Diagnostics, Inc
GNMK
| $215K | ﹤0.01% |
9,011
-4,203
| -32% | -$100K |
|
2342
KalVista Pharmaceuticals
KALV
$705M
| $215K | ﹤0.01% |
8,374
+5,417
| +183% | +$139K |
|
2343
Johnson Outdoors
JOUT
$422M
| $215K | ﹤0.01% |
1,507
+289
| +24% | +$41.3K |
|
2344
Arrow Financial
AROW
$478M
| $214K | ﹤0.01% |
7,034
+3,034
| +76% | +$92.5K |
|
2345
Cross Country Healthcare
CCRN
$411M
| $214K | ﹤0.01% |
17,164
+7,811
| +84% | +$97.6K |
|
|
CONN
2346
DELISTED
Conn's Inc.
CONN
| $214K | ﹤0.01% |
10,986
+2,074
| +23% | +$40.3K |
|
2347
Bar Harbor Bankshares
BHB
$540M
| $213K | ﹤0.01% |
7,252
+3,057
| +73% | +$89.9K |
|
2348
Inovio Pharmaceuticals
INO
$126M
| $213K | ﹤0.01% |
1,915
-2,894
| -60% | -$322K |
|
2349
Dorian LPG
LPG
$1.35B
| $213K | ﹤0.01% |
16,188
+7,298
| +82% | +$95.8K |
|
|
MGI
2350
DELISTED
MoneyGram International, Inc. New
MGI
| $212K | ﹤0.01% |
32,321
+14,907
| +86% | +$97.9K |
|